ThermoGenesis Holdings, Inc.
THMO
|
$0.6695
3.0%
2.91%
8.6K
|
Health Technology
(0.0% 1d) (-13.0% 1m) (-69.4% 1y) (0.0% 2d) (0.0% 3d) (-25.2% 7d) (-52.35% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 5,324,386
http://www.thermogenesis.com
Sec Filling | Patents | 50 employees
(US) ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
gene therapies stem cell t-cell ceiling
add to watch list Paper trade email alert is off
Press-releases
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
Published: 2024-04-09 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -2.71%
H: 0.52%
C: 0.24%
AVTR | $24.1 -0.82% 0.25% 4.7M
|
Process Industries
|
| O: -1.7%
H: 1.08%
C: 0.55%
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: 4.99%
H: 2.78%
C: -2.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
global growth market
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-13 (Crawled : 21:00) - prnewswire.com
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: -10.74%
H: 0.0%
C: -7.96%
update financial results
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
Published: 2023-11-08 (Crawled : 22:00) - biospace.com/
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: -0.73%
H: 4.53%
C: 2.16%
update financial results
Automated and Closed Cell Therapy Processing Systems Industry, 2030: Leading Market Players Channeling Significant Investments into Automating Cell Therapy Processes
Published: 2023-11-03 (Crawled : 10:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
|
| O: -0.28%
H: 4.55%
C: 0.01%
TRUMY | $16.507 0.79% 34K
|
Manufacturing
|
| O: 3.89%
H: 0.0%
C: -1.74%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: 1.56%
H: 2.05%
C: 0.96%
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: 1.99%
H: 3.96%
C: 3.96%
investments cell therapy market
H.C. Wainwright 25th Annual Global Investment Conference (2023)
Published: 2023-09-13 (Crawled : 21:00) - thermogenesis.com
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: -0.85%
H: 3.92%
C: 0.85%
conference global
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-06 (Crawled : 13:00) - thermogenesis.com
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: -2.5%
H: 2.56%
C: 0.85%
conference global
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-10 (Crawled : 20:00) - prnewswire.com
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: -5.72%
H: 0.0%
C: -6.22%
update financial results
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-15 (Crawled : 20:00) - prnewswire.com
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: -1.93%
H: 5.56%
C: 1.1%
update financial results
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update
Published: 2023-05-10 (Crawled : 13:00) - thermogenesis.com
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: -2.01%
H: 5.13%
C: 2.05%
update financial results
ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update
Published: 2023-03-30 (Crawled : 20:00) - thermogenesis.com
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: 4.31%
H: 1.88%
C: -1.5%
year update financial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0000897069-23-001629 | 4 | 2023-11-21 | 2023-11-17 | Sell | S | 600000 | 327121 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10